RACHEL NEWHOUSE: Open Payments
NPI 1942924576 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$562 in 25 payments from 12 companies in 2025. Trend: 2023 $777 · 2024 $750 · 2025 $562
Food & beverage: $562
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $122 |
| Boston Scientific Corporation | 4 | $100 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $91 |
| Alnylam Pharmaceuticals Inc. | 3 | $73 |
| SCPHARMACEUTICALS INC. | 2 | $39 |
| Actelion Pharmaceuticals US, Inc. | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $19 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $15 |
Products named: WATCHMAN FLX, VYNDAQEL, JARDIANCE, ONPATTRO, FUROSCIX, OPSYNVI, VERQUVO, LEQVIO.
Industry payments across MI — which companies pay providers there.
